LeonaBio's top three insider shareholders as of May 30, 2026 are Glenna Mileson (Chief Financial Officer, 159.93K shares), Hans Moebius (Chief Medical Officer, 91.48K shares), Mark James Litton (President And Ceo, 57.93K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Mark James Litton | President And Ceo | 57,926 | 0 | 05 Mar, 2026 |
| Glenna Mileson | Chief Financial Officer | 159,930 | 0 | 30 Dec, 2022 |
| Hans Moebius | Chief Medical Officer | 91,482 | 0 | 08 Jan, 2024 |
| Kevin Church | Chief Scientific Officer | 25,178 | 0 | 05 Mar, 2026 |
| Rachel Lenington | Coo And Cdo | 20,870 | 0 | 05 Sep, 2024 |
| Mark Worthington | General Counsel And Cco | 18,376 | 0 | 05 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Apr, 2026 | Robert Renninger | Stock Option (Right to Buy) | A | 300,000 | $0.00 | 300,000 | D | A |
| 09 Apr, 2026 | Mark James Litton | Stock Option (Right to Buy) | A | 750,000 | $0.00 | 750,000 | D | A |
| 09 Apr, 2026 | Barbara Kosacz | Stock Option (Right to Buy) | A | 28,000 | $0.00 | 28,000 | D | A |
| 09 Apr, 2026 | Mark Worthington | Stock Option (Right to Buy) | A | 300,000 | $0.00 | 300,000 | D | A |
| 09 Apr, 2026 | Mark James Litton | Stock Option (Right to Buy) | A | 750,000 | $0.00 | 750,000 | D | A |
| 09 Apr, 2026 | Kevin Church | Stock Option (Right to Buy) | A | 300,000 | $0.00 | 300,000 | D | A |
| 09 Apr, 2026 | Kelly A Romano | Stock Option (Right to Buy) | A | 28,000 | $0.00 | 28,000 | D | A |
| 09 Apr, 2026 | John M Jr Fluke | Stock Option (Right to Buy) | A | 28,000 | $0.00 | 28,000 | D | A |
| 09 Apr, 2026 | Martin Javier San | Stock Option (Right to Buy) | A | 350,000 | $0.00 | 350,000 | D | A |
| 03 Mar, 2026 | Mark Worthington | Common Stock | A | 5,726 | $0.00 | 19,704 | D | M |
| 03 Mar, 2026 | Mark James Litton | Common Stock | A | 22,254 | $0.00 | 63,082 | D | M |
| 03 Mar, 2026 | Mark James Litton | Common Stock | A | 22,254 | $0.00 | 63,082 | D | M |
| 03 Mar, 2026 | Kevin Church | Common Stock | A | 5,856 | $0.00 | 26,537 | D | M |
| 03 Mar, 2026 | Mark James Litton | Common Stock | A | 22,254 | $0.00 | 63,082 | D | M |
| 04 Mar, 2026 | Mark James Litton | Common Stock | D | 5,156 | $5.37 | 57,926 | D | S |
| 04 Mar, 2026 | Mark James Litton | Common Stock | D | 5,156 | $5.37 | 57,926 | D | S |
| 04 Mar, 2026 | Mark James Litton | Common Stock | D | 5,156 | $5.37 | 57,926 | D | S |
| 04 Mar, 2026 | Mark Worthington | Common Stock | D | 1,328 | $5.37 | 18,376 | D | S |
| 04 Mar, 2026 | Kevin Church | Common Stock | D | 1,359 | $5.37 | 25,178 | D | S |
| 03 Mar, 2026 | Mark Worthington | Restricted Stock Units | D | 5,726 | $0.00 | 0 | D | M |